First there was blackmail on the stock market equivalence. It was then the medical technology sector (medtech) which fell into the nets of the negotiations between Bern and Brussels on the institutional framework agreement. In recent weeks, the tension has risen a notch: the players in this branch brandish the threat of a shortage of medical equipment in Europe.
At the origin of their fears is an unmistakable technical-political imbroglio, which has its roots in the reform of European regulations on medical devices. Born in the wake of the scandal of defective breast implants in France, the reform toughens the requirements for the certification of medical devices. After a one-year postponement, it will come into force on May 26th.
–
–
